National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional)
Funding Opportunity PAR-18-230 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and clinical research on mental health, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new indi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Funding Opportunity PAR-18-174 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development ofsmall-molecule and biologic therapeutic agents that prevent Alzheimer's disease (AD), slow its progression or treat its cognitive and behavioral symptoms.Participants in this program will receive funding for therapy development activities such as medicinal chemistry, pharmacokinetics (PK), Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET), efficacy in animal models, formulat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2017 Category: Research Source Type: funding
NINDS CREATE Bio Optimization Track for Biologics (U01)
Funding Opportunity PAR-17-456 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the optimization of potential therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene and cell therapies) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic lead(s) that showed promise as a potential therapeutic agent as evidenced by convincing animal proof-of-concept studies. Therefore, at the end of this funding period, successful projects will have delivered and optimiz...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 14, 2017 Category: Research Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
Funding Opportunity ID: 292335 Opportunity Number: PAR-17-205 Opportunity Title: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthIncome Security and Social ServicesCategory Explanation: CFDA Number(s): 93.12193.21393.24293.27393.27993.85393.86593.86693.867Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governme...
Source: Grants.gov - March 9, 2017 Category: Research Tags: Education Health Income Security and Social Services Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
Funding Opportunity ID: 292353 Opportunity Number: PAR-17-201 Opportunity Title: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthIncome Security and Social ServicesCategory Explanation: CFDA Number(s): 93.12193.21393.24293.27393.27993.85393.86593.86693.867Eligible Applicants: Small businessesAdditional Information on Eligibility: Other Eligible Applicants include th...
Source: Grants.gov - March 9, 2017 Category: Research Tags: Education Health Income Security and Social Services Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
Funding Opportunity ID: 260046 Opportunity Number: PAR-14-292 Opportunity Title: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthIncome Security and Social ServicesCategory Explanation: CFDA Number(s): 93.12193.21393.24293.27393.27993.85393.865Eligible Applicants: Small businessesAdditional Information on Eligibility: Other Eligible Applicants include the following:...
Source: Grants.gov - March 9, 2017 Category: Research Tags: Education Health Income Security and Social Services Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)
Funding Opportunity ID: 260047 Opportunity Number: PAR-14-293 Opportunity Title: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthIncome Security and Social ServicesCategory Explanation: CFDA Number(s): 93.12193.21393.24293.27393.27993.85393.86593.866Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsInd...
Source: Grants.gov - March 9, 2017 Category: Research Tags: Education Health Income Security and Social Services Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
Funding Opportunity PAR-17-205 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2017 Category: Research Source Type: funding
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
Funding Opportunity PAR-17-201 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) encourages applications from small businesses seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract resear...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 9, 2017 Category: Research Source Type: funding
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19)
Funding Opportunity ID: 292143 Opportunity Number: PAR-17-186 Opportunity Title: National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.24293.27393.279Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State contro...
Source: Grants.gov - March 1, 2017 Category: Research Tags: Education Health Source Type: funding
National Cooperative Drug/Device Discovery/Development Groups (U01)
Funding Opportunity ID: 292117 Opportunity Number: PAR-17-185 Opportunity Title: National Cooperative Drug/Device Discovery/Development Groups (U01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.24293.27393.279Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally r...
Source: Grants.gov - March 1, 2017 Category: Research Tags: Education Health Source Type: funding
National Cooperative Drug/Device Discovery/Development Groups (U01)
Funding Opportunity PAR-17-185 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and clinical research on mental health, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new indi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 1, 2017 Category: Research Source Type: funding
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19)
Funding Opportunity PAR-17-186 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and clinical research on mental disorders, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new i...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 1, 2017 Category: Research Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)
Funding Opportunity ID: 259793 Opportunity Number: PAR-14-287 Opportunity Title: NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.853Eligible Applicants: Small businessesAdditional Information on Eligibility: Other Eligible Applicants include the following:Only United States small business concerns (SBCs) are eligible to submit applications f...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)
Funding Opportunity ID: 259790 Opportunity Number: PAR-14-286 Opportunity Title: NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.853Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative Ameri...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
